Jebel Pharm Запускает Jiangsu Jebel Robotics к Expand ИИ и Robotics Innovation

Jebel Pharm has officially established a new subsidiary, Jiangsu Jebel Robotics Co., Ltd., marking a major step into the fields of artificial intelligence and intelligent robotics. With a registered capital of RMB 51 million, the company will focus on cutting-edge areas such as smart robotics development, AI system integration, and AI software applications.

The new venture reflects Jebel Pharm’s strategic push toward diversification and innovation. The company is jointly owned by Jebel Pharm and co-investor Chenhang Tan, combining strong pharmaceutical industry experience with advanced technological capabilities.

Jiangsu Jebel Robotics will develop intelligent, customizable robotic solutions for various industries and explore deeper integration of AI technologies within the pharmaceutical sector. This cross-industry initiative aims to drive digital transformation and enhance operational efficiency in healthcare and beyond.

As AI and robotics become key drivers of industrial innovation, Jebel Pharm’s new venture is poised to play a vital role in accelerating intelligent solutions and contributing to the future of smart technologies.